To provide more evidence for our conclusions, we constructed anti-CD70 CAR-T cells following our previous studies to validate the ability of AZD1208 to reverse hypoxia-induced damage and enhance CAR-T cell anti-tumor function (Figure S3A-B) [35, 45]. Here, CD70 is linked to neoplasm.